Report cover image

Global Pneumococcal Vaccine Market Growth, Size, Trends Analysis - By Vaccine Type, By Product, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Oct 13, 2025
Length 244 Pages
SKU # SPER20565941

Description

Pneumococcal Vaccine Market Introduction and Overview

According to SPER market research, ‘Global Pneumococcal Vaccine Market Size- By Vaccine Type, By Product, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ states that the Global Pneumococcal Vaccine Market is predicted to reach 16.02 billion by 2034 with a CAGR of 6.43%.

The bacteria that cause pneumonia, meningitis, and bloodstream infections is Streptococcus pneumoniae. The goal of pneumococcal vaccinations is to shield against infections caused by this pathogen. These vaccines work by stimulating the immune system to recognize and respond to specific pneumococcal serotypes. Pneumococcal conjugate vaccines (PCVs), which provide strong and long-lasting immunity to infants and young children, and pneumococcal polysaccharide vaccines (PPSVs), which are primarily used for high-risk populations and older adults, are the two main types that are frequently used.

Restraints:

There are several challenges facing the pneumococcal vaccine market that restrict its expansion and accessibility. The constant emergence of new serotypes that are not covered by existing formulations necessitates ongoing research and development, which drives up costs. High production costs and intricate manufacturing processes limit affordability for low- and middle-income countries. Price competition in public tenders puts pressure on margins, but differences in national vaccination protocols and regulatory requirements may delay the adoption of products.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered By

Vaccine Type, By Product, By End Use

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Serum Institute of India Pvt. Ltd., CSL
Sanofi, GSK plc, Merck & Co., Inc., Pfizer Inc., Walvax Biotechnology Co., Ltd
Beijing Minhai Biotechnology Co., Ltd

Global Pneumococcal Vaccine Market Segmentation:

By Vaccine Type: Based on the Vaccine Type, Global Pneumococcal Vaccine Market is segmented as; Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine.

By Product: Based on the Product, Global Pneumococcal Vaccine Market is segmented as; Prevnar 13, Synflorix, Pneumovax 23, VAXNEUVANCE, PNEUMOSIL.

By End User: Based on the End User, Global Pneumococcal Vaccine Market is segmented as; Public Sector, Private Sector.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

244 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Pneumococcal Vaccine Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pneumococcal Vaccine Market
7. Global Pneumococcal Vaccine Market, By Vaccine Type (USD Million) 2021-2034
7.1. Pneumococcal Conjugate Vaccine
7.2. Pneumococcal Polysaccharide Vaccine
8. Global Pneumococcal Vaccine Market, By Product (USD Million) 2021-2034
8.1. Prevnar 13
8.2. Synflorix
8.3. Pneumovax 23
8.4. VAXNEUVANCE
8.5. PNEUMOSIL
8.6. Other Products
9. Global Pneumococcal Vaccine Market, By End User (USD Million) 2021-2034
9.1. Public Sector
9.2. Private Sector
10. Global Pneumococcal Vaccine Market, (USD Million) 2021-2034
10.1. Global Pneumococcal Vaccine Market Size and Market Share
11. Global Pneumococcal Vaccine Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Serum Institute of India Pvt. Ltd
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. CSL
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Sanofi
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. GSK plc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Merck & Co., Inc
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Pfizer Inc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Walvax Biotechnology Co., Ltd
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Beijing Minhai Biotechnology Co., Ltd
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us